193 related articles for article (PubMed ID: 33094961)
1. A Preclinical Animal Study of Combined Intragastric Balloon and Duodenal-Jejunal Bypass Liner for Obesity and Metabolic Disease.
Ghoz H; Jaruvongvanich V; Matar R; Beran A; Maselli DB; Storm AC; Abu Dayyeh BK
Clin Transl Gastroenterol; 2020 Sep; 11(9):e00234. PubMed ID: 33094961
[TBL] [Abstract][Full Text] [Related]
2. Weight loss and metabolic improvement in morbidly obese subjects implanted for 1 year with an endoscopic duodenal-jejunal bypass liner.
Escalona A; Pimentel F; Sharp A; Becerra P; Slako M; Turiel D; Muñoz R; Bambs C; Guzmán S; Ibáñez L; Gersin K
Ann Surg; 2012 Jun; 255(6):1080-5. PubMed ID: 22534421
[TBL] [Abstract][Full Text] [Related]
3. Is duodeno-jejunal bypass liner superior to pylorus preserving bariatric surgery in terms of complications and efficacy?
Balint IB; Csaszar F; Somodi K; Ternyik L; Biro A; Kaposztas Z
Langenbecks Arch Surg; 2021 Aug; 406(5):1363-1377. PubMed ID: 33712874
[TBL] [Abstract][Full Text] [Related]
4. The effect of the endoscopic duodenal-jejunal bypass liner on obesity and type 2 diabetes mellitus, a multicenter randomized controlled trial.
Koehestanie P; de Jonge C; Berends FJ; Janssen IM; Bouvy ND; Greve JW
Ann Surg; 2014 Dec; 260(6):984-92. PubMed ID: 25072436
[TBL] [Abstract][Full Text] [Related]
5. Design of the Weight-loss Endoscopy Trial (WET): a multi-center, randomized, controlled trial comparing weight loss in endoscopically implanted duodenal-jejunal bypass liners vs. intragastric balloons vs. a sham procedure.
Hollenbach M; Prettin C; Gundling F; Schepp W; Seufert J; Stein J; Rösch T; Aberle J; Feisthammel J; Petroff D; Hoffmeister A
BMC Gastroenterol; 2018 Jul; 18(1):118. PubMed ID: 30021518
[TBL] [Abstract][Full Text] [Related]
6. Endocrine effects of duodenal-jejunal exclusion in obese patients with type 2 diabetes mellitus.
Kaválková P; Mráz M; Trachta P; Kloučková J; Cinkajzlová A; Lacinová Z; Haluzíková D; Beneš M; Vlasáková Z; Burda V; Novák D; Petr T; Vítek L; Pelikánová T; Haluzík M
J Endocrinol; 2016 Oct; 231(1):11-22. PubMed ID: 27474690
[TBL] [Abstract][Full Text] [Related]
7. Intragastric balloons appear safer and better than the endoscopic duodenojejunal bypass liners (DJBL) for preoperative weight loss in bariatric surgery.
Gagner M
Gastrointest Endosc; 2011 Apr; 73(4):850-1; author reply 851-2. PubMed ID: 21457827
[No Abstract] [Full Text] [Related]
8. Beneficial Metabolic Effects of Duodenal Jejunal Bypass Liner for the Treatment of Adipose Patients with Type 2 Diabetes Mellitus: Analysis of Responders and Non-Responders.
Stratmann B; Krepak Y; Schiffer E; Jarick I; Hauber M; Lee-Barkey YH; Fischer M; Tschoepe D
Horm Metab Res; 2016 Sep; 48(10):630-637. PubMed ID: 27589345
[TBL] [Abstract][Full Text] [Related]
9. Relevant Weight Reduction and Reversed Metabolic Co-morbidities Can Be Achieved by Duodenojejunal Bypass Liner in Adolescents with Morbid Obesity.
Homan M; Kovač J; Orel R; Battelino T; Kotnik P
Obes Surg; 2020 Mar; 30(3):1001-1010. PubMed ID: 31758471
[TBL] [Abstract][Full Text] [Related]
10. Endoscopic duodenal-jejunal bypass liner rapidly improves type 2 diabetes.
de Jonge C; Rensen SS; Verdam FJ; Vincent RP; Bloom SR; Buurman WA; le Roux CW; Schaper NC; Bouvy ND; Greve JW
Obes Surg; 2013 Sep; 23(9):1354-60. PubMed ID: 23526068
[TBL] [Abstract][Full Text] [Related]
11. Weight reduction and improvement in diabetes by the duodenal-jejunal bypass liner: a 198 patient cohort study.
Betzel B; Homan J; Aarts EO; Janssen IMC; de Boer H; Wahab PJ; Groenen MJM; Berends FJ
Surg Endosc; 2017 Jul; 31(7):2881-2891. PubMed ID: 27804045
[TBL] [Abstract][Full Text] [Related]
12. Comparative efficacy and safety of the duodenal-jejunal bypass liner in obese patients with type 2 diabetes mellitus: A case control study.
Laubner K; Riedel N; Fink K; Holl RW; Welp R; Kempe HP; Lautenbach A; Schlensak M; Stengel R; Eberl T; Dederichs F; Schwacha H; Seufert J; Aberle J
Diabetes Obes Metab; 2018 Aug; 20(8):1868-1877. PubMed ID: 29569313
[TBL] [Abstract][Full Text] [Related]
13. Baseline glycated hemoglobin levels are associated with duodenal-jejunal bypass liner-induced weight loss in obese patients.
Muñoz R; Dominguez A; Muñoz F; Muñoz C; Slako M; Turiel D; Pimentel F; Sharp A; Escalona A
Surg Endosc; 2014 Apr; 28(4):1056-62. PubMed ID: 24196558
[TBL] [Abstract][Full Text] [Related]
14. The Effect of 6 and 12 months Duodenal-Jejunal Bypass Liner Treatment on Obesity and Type 2 Diabetes: a Crossover Cohort Study.
van Rijn S; Betzel B; de Jonge C; van Dijk DPJ; Janssen IM; Berends FJ; Bouvy ND; Greve JWM
Obes Surg; 2018 May; 28(5):1255-1262. PubMed ID: 29110244
[TBL] [Abstract][Full Text] [Related]
15. Is reimplantation of the duodenal-jejunal bypass liner feasible?
Koehestanie P; Betzel B; Aarts EO; Janssen IM; Wahab P; Berends FJ
Surg Obes Relat Dis; 2015; 11(5):1099-104. PubMed ID: 25979208
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of the Duodeno-Jejunal Bypass Liner in Patients With Metabolic Syndrome: A Multicenter Randomized Controlled Trial (ENDOMETAB).
Caiazzo R; Branche J; Raverdy V; Czernichow S; Carette C; Robert M; Disse E; Barthet M; Cariou B; Msika S; Behal H; Denies F; Dervaux B; Duhamel A; Verkindt H; Pattou F
Ann Surg; 2020 Nov; 272(5):696-702. PubMed ID: 32889869
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal evaluation of efficacy, safety and nutritional status during one-year treatment with the duodenal-jejunal bypass liner.
Riedel N; Laubner K; Lautenbach A; Schön G; Schlensak M; Stengel R; Eberl T; Dederichs F; Aberle J; Seufert J
Surg Obes Relat Dis; 2018 Jun; 14(6):769-779. PubMed ID: 29650340
[TBL] [Abstract][Full Text] [Related]
18. Adverse Events of the Duodenal-Jejunal Bypass Liner: a Systematic Review.
Betzel B; Drenth JPH; Siersema PD
Obes Surg; 2018 Nov; 28(11):3669-3677. PubMed ID: 30121857
[TBL] [Abstract][Full Text] [Related]
19. Long-term effects of proximal small bowel exclusion by duodenal-jejunal bypass liner on weight reduction and glycemic control in diabetic patients.
Deutsch L; Ben Haim L; Sofer Y; Gluck N; Santo E; Fishman S
Surg Obes Relat Dis; 2018 Oct; 14(10):1561-1569. PubMed ID: 30449512
[TBL] [Abstract][Full Text] [Related]
20. Duodenal-jejunal lining increases postprandial unconjugated bile acid responses and disrupts the bile acid-FXR-FGF19 axis in humans.
van Nierop FS; de Jonge C; Kulik W; Bouvy N; Schaap FG; Olde Damink SW; Rensen S; Romijn JA; Greve JWM; Soeters MR
Metabolism; 2019 Apr; 93():25-32. PubMed ID: 30658059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
